compounding glp-1 news Hims Inc FDA GLP-1 Alert: California Compounding

If you're taking Wegovy, Ozempic, or Zepbound, you already know these medications work

Clinical evidence remains limited

The glp-1 agonists market is expected to reach US$ 118,926.1 billion by 2032, growing at a significant CAGR of 18.1% from 2026 to 2032.

Achieve your weight loss goals with medically guided treatments at Original Glam in Denver

Glucose-dependent insulinotropic polypeptide (GIP) is an intestinal hormone that potentiates glucose-induced insulin secretion in the postprandial state

GLP-1 receptor agonists trace their roots back to exendin-4, a peptide isolated from Gila monster venom in the early 1990san insight that eventually led to exenatide and reshaped the treatment of diabetes and metabolic disease